Clinical Trial Update: Efficacy and Safety Phase II Study of SR-T100 to Treat Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase II trial evaluating SR-T100 for actinic keratosis has completed, reporting data on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• SR-T100

Snippet

Sponsor: G&E Herbal Biotechnology Co., LTD | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED